Ownership history in D. E. Shaw & Co., Inc. · 14 quarters on record
This page tracks every 13F SEC filing in which D. E. Shaw & Co., Inc. reported a position in ESTRELLA IMMUNOPHARMA INC (ESLAW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 87,500 | — | 0% | 0.00% | $4K | — |
| 2025 Q3 | UNCHANGED | 87,500 | — | 0% | 0.00% | $5K | — |
| 2025 Q2 | UNCHANGED | 87,500 | — | 0% | 0.00% | $4K | — |
| 2025 Q1 | UNCHANGED | 87,500 | — | 0% | 0.00% | $7K | — |
| 2024 Q4 | UNCHANGED | 87,500 | — | 0% | 0.00% | $8K | — |
| 2024 Q3 | UNCHANGED | 87,500 | — | 0% | 0.00% | $6K | — |
| 2024 Q2 | UNCHANGED | 87,500 | — | 0% | 0.00% | $7K | — |
| 2024 Q1 | UNCHANGED | 87,500 | — | 0% | 0.00% | $6K | — |
| 2023 Q4 | UNCHANGED | 87,500 | — | 0% | 0.00% | $4K | — |
| 2000 Q2 | UNCHANGED | 87,500 | — | 0% | 0.00% | $4K | — |
As of 2025 Q4 — sorted by position size